page_banner

product

5-Fluorouracil(CAS# 51-21-8)

Chemical Property:

Molecular Formula C4H3FN2O2
Molar Mass 130.08
Density 1.4593 (estimate)
Melting Point 282-286 °C (dec.) (lit.)
Boling Point 190-200°C/0.1mmHg
Water Solubility 12.2 g/L 20 ºC
Solubility Slightly soluble in ethanol. It is almost insoluble in chloroform and dissolved in sodium hydroxide solution.
Appearance White or white-like crystalline powder
Color white
Merck 14,4181
BRN 127172
pKa pKa 8.0±0.1 (H2O) (Uncertain);3.0±0.1(H2O) (Uncertain)
PH 4.3-5.3 (10g/l, H2O, 20℃)
Storage Condition 2-8°C
Stability Stable. Light sensitive. Combustible. Incompatible with strong oxidizing agents, strong bases.
Sensitive Air Sensitive
Refractive Index 1.542
MDL MFCD00006018
Physical and Chemical Properties melting point 282-286°C (dec.)(lit.)storage conditions Store at 0-5
solubility H2O: 10 mg/mL, clear

form powder

color white

water solubility 12.2g/L 20 oC
Sensitive Air
merck 14,4181
BRN 127172

Use For digestive system cancer, head and neck cancer, gynecological cancer, lung cancer, liver cancer, bladder cancer and skin cancer treatment

Product Detail

Product Tags

Risk Codes R22 – Harmful if swallowed
R20/21/22 – Harmful by inhalation, in contact with skin and if swallowed.
R52 – Harmful to aquatic organisms
R25 – Toxic if swallowed
Safety Description S36 – Wear suitable protective clothing.
S36/37 – Wear suitable protective clothing and gloves.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.
S22 – Do not breathe dust.
S45 – In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S26 – In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
UN IDs UN 2811 6.1/PG 3
WGK Germany 3
RTECS YR0350000
FLUKA BRAND F CODES 10-23
TSCA T
HS Code 29335995
Hazard Note Irritant/Highly Toxic
Hazard Class 6.1
Packing Group III
Toxicity LD50 orally in Rabbit: 230 mg/kg

 

Introduction

This product is first converted into 5-fluoro-2-deoxyuracil nucleotides in the body, which inhibits thymine nucleotide synthase and blocks the conversion of deoxyuracil nucleotides into deoxythymine nucleotides, thereby inhibiting DNA biosynthesis. In addition, by preventing the incorporation of uracil and rotic acid into RNA, the effect of inhibiting RNA synthesis is achieved. This product is a cell cycle specific drug, mainly inhibiting S phase cells.


  • Previous:
  • Next:

  • Write your message here and send it to us